ArticleFrontiers in endocrinology2026
Clinical characteristics and associated risk factors for diminished ovarian reserve among Chinese women: a matched case-control study.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association between heavy metals, essential trace elements in follicular fluid and diminished ovarian reserve: a hospital-based case-control study.Frontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Diminished ovarian reserve (DOR) has emerged as a significant reproductive challenge and a broader societal concern. Most previous studies have focused on ovarian reserve markers, while limited research has examined DOR as a primary outcome, and the potential association between TORCH infections (toxoplasmosis, others, rubella, cytomegalovirus, herpes) and DOR risk remains unclear. Methods: A matched case-control study was conducted among women aged 20-47 years who sought assisted reproductive technology at a maternity hospital in Sichuan, China, between January 2022 and August 2024. DOR was diagnosed according to the Consensus on clinical diagnosis and management of diminished ovarian reserve from China. Age-matched controls (1:1) with normal ovarian reserve were selected. Conditional logistic regression was used to identify factors associated with DOR, with multivariable models adjusting for confounders. Subgroup analyses by age and body mass index (BMI) were conducted to examine robustness and effect modification. Results: A total of 3,751 DOR cases were matched to 3,751 controls (median age: 36 years). DOR group had significantly higher FSH, E2, and LH levels (P < 0.01), and lower AFC, AMH, PRL, and T levels (P < 0.001) compared to controls. Multivariable logistic regression showed that non-Han ethnicity (OR = 1.278, 95% CI: 1.115-1.466), manual labor (OR = 1.181, 95% CI: 1.002-1.392), obesity (OR = 1.316, 95% CI: 1.044-1.660), light menstrual flow (OR = 1.262, 95% CI: 1.111-1.435), and T. gondii infection (OR = 2.292, 95% CI: 1.683-3.122) were independently associated with DOR. In women aged 20-35 years, ≥2 pregnancies (OR = 0.712, 95% CI: 0.615-0.824), and infections with T. gondii (OR = 23.750, 95% CI: 13.330-42.316), CMV (OR = 8.189, 95% CI: 5.821-11.521), and RV (OR = 8.132, 95% CI: 5.806-11.390) were strongly associated with DOR, with no such associations observed in the 36-47 years group. Significant age interactions were detected (P < 0.05). Conclusion: Ethnicity, obesity, menstrual flow, pregnancy history, and TORCH infections were significantly associated with DOR, with age-related effect modification observed for pregnancy history and infections. Prospective studies are needed to elucidate the underlying mechanisms, particularly the role of infections and immune response.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.